Prenatal diagnosis and genetic study of 22q11.2 microduplication in Chinese fetuses: A series of 31 cases and literature review
Molecular Genetics & Genomic Medicine · 2024
DOI: 10.1002/mgg3.2498 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Genetics & Genomic Medicine, 2024. Verfasst von Xiali Jiang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical Genetic Diagnosis and Therapy Center, Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and…. Hauptthemen laut MEDLINE: DiGeorge Syndrome. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Key Project on the Integration of Industry, Education and Research Collaborative Innovation of Fujian Province, Joints Funds for the Innovation of Science and Technology, Fujian Province, Key Project on Science and Technology Program of Fujian Health Commission.
Abstract (Originalsprache)
Background
Patients with 22q11.2 microduplication syndrome exhibit a high degree of phenotypic heterogeneity and incomplete penetrance, making prenatal diagnosis challenging due to phenotypic variability. This report aims to raise awareness among prenatal diagnostic practitioners regarding the variant's complexity, providing a basis for prenatal genetic counseling.
Methods
Family and clinical data of 31 fetuses with 22q11.2 microduplications confirmed by chromosomal microarray between June 2017 and June 2023 were considered.
Results
Primary prenatal ultrasound features of affected fetuses include variable cardiac and cardiovascular anomalies, increased nuchal translucency (≥3 mm), renal abnormalities, and polyhydramnios. More than half of fetuses considered showed no intrauterine manifestations; therefore, prenatal diagnostic indicators were primarily advanced maternal age or high‐risk Down syndrome screening. Most fetuses had microduplications in proximal or central 22q11.2 regions, with only three cases with distal microduplications. Among parents of fetuses considered, 87% (27/31) continued the pregnancy. During follow‐up, 19 cases remained clinically asymptomatic.
Conclusion
Nonspecific 22q11.2 microduplication features in fetuses and its mild postnatal disease presentation highlight the need to cautiously approach prenatal diagnosis and pregnancy decision‐making. Increased clinical efforts should be made regarding providing parents with specialized genetic counseling, long‐term follow‐up, and fetal risk information.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Genetic Diagnosis and Therapy Center, Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Key Laboratory for Prenatal Diagnosis and Birth De…
ORCID-Profile: Bin Liang, Xiaoqing Wu, Yan Wang
Förderung
- Key Project on the Integration of Industry, Education and Research Collaborative Innovation of Fujian Province
- Joints Funds for the Innovation of Science and Technology, Fujian Province
- Key Project on Science and Technology Program of Fujian Health Commission
Zitieren
APA
Jiang, X., Liang, B., He, S., Wu, X., Zhao, W., Xue, H., Wang, Y., Lin, N., Huang, H., & Xu, L. (2024). Prenatal diagnosis and genetic study of 22q11.2 microduplication in Chinese fetuses: A series of 31 cases and literature review. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.2498
Vancouver
Jiang X, Liang B, He S, Wu X, Zhao W, Xue H, et al. Prenatal diagnosis and genetic study of 22q11.2 microduplication in Chinese fetuses: A series of 31 cases and literature review. Molecular Genetics & Genomic Medicine. 2024. doi:10.1002/mgg3.2498
BibTeX
@article{Jiang2024,
author = {Jiang, Xiali and Liang, Bin and He, Shuqiong and Wu, Xiaoqing and Zhao, Wantong and Xue, Huili and Wang, Yan and Lin, Na and Huang, Hailong and Xu, Liangpu},
title = {Prenatal diagnosis and genetic study of 22q11.2 microduplication in Chinese fetuses: A series of 31 cases and literature review},
journal = {Molecular Genetics & Genomic Medicine},
year = {2024},
doi = {10.1002/mgg3.2498}
}
EUVIMED